AdOnce-daily oral therapy for patients with HER2+ eBC or mBC. Visit the site to learn more. Help reduce the risk of recurrence in HER2+ eBC. See efficacy and safety info.
AdUnderstand Treatment & Dosing of This Option in HR+/HER2- Metastatic Breast Cancer. Visit the Site to View a Treatment Option in HR+/HER2- Metastatic Breast Cancer.
AdVisit Our Pathologist Site To Learn More About HER2 in Breast & Gastric Cancer. Practice Your HER2 IHC Scoring With Clinical Cases Selected By Our Pathology Faculty.